These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6099779

  • 1. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone secretion.
    Maser-Gluth C, Toygar A, Schaz K, Vecsei P.
    Clin Exp Hypertens A; 1984; 6(10-11):2097-100. PubMed ID: 6099779
    [Abstract] [Full Text] [Related]

  • 2. Time course of plasma corticosterone, 18-hydroxycorticosterone and aldosterone concentrations following CRF administration in the rat. A phase of corticosterone inhibition.
    Maser-Gluth C, Toygar A, Vecsei P.
    Life Sci; 1984 Aug 20; 35(8):879-84. PubMed ID: 6090854
    [Abstract] [Full Text] [Related]

  • 3. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
    Miyamori I, Yasuhara S, Matsubara T, Okamoto S, Ikeda M, Koshida H, Morise T, Takeda Y, Takeda R, Vecsei P.
    Endocrinol Jpn; 1987 Dec 20; 34(6):809-19. PubMed ID: 2836182
    [Abstract] [Full Text] [Related]

  • 4. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
    Oelkers W, Boelke T, Bähr V.
    J Clin Endocrinol Metab; 1988 Jan 20; 66(1):181-6. PubMed ID: 2826525
    [Abstract] [Full Text] [Related]

  • 5. 18-hydroxycorticosterone: a review.
    Fraser R, Lantos CP.
    J Steroid Biochem; 1978 Mar 20; 9(3):273-86. PubMed ID: 25994
    [No Abstract] [Full Text] [Related]

  • 6. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents.
    Pralong FP, Corder R, Gaillard RC.
    Regul Pept; 1991 Feb 01; 32(2):217-26. PubMed ID: 1852030
    [Abstract] [Full Text] [Related]

  • 7. Corticotropin releasing factor increases the adrenocortical responsiveness to adrenocorticotropin.
    De Souza E, Van Loon GR.
    Experientia; 1984 Sep 15; 40(9):1004-6. PubMed ID: 6088279
    [Abstract] [Full Text] [Related]

  • 8. The conversion of 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone to aldosterone by rat adrenal tissue: evidence for an alternative biosynthetic pathway.
    Müller J.
    J Steroid Biochem; 1980 Mar 15; 13(3):245-51. PubMed ID: 7392603
    [No Abstract] [Full Text] [Related]

  • 9. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
    Iwasaki R, Kigoshi T, Uchida K, Morimoto S.
    Acta Endocrinol (Copenh); 1989 Jul 15; 121(1):83-9. PubMed ID: 2545066
    [Abstract] [Full Text] [Related]

  • 10. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
    Sowers JR, Beck FW.
    J Endocrinol Invest; 1984 Oct 15; 7(5):473-9. PubMed ID: 6096435
    [Abstract] [Full Text] [Related]

  • 11. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C, Vale W.
    J Clin Invest; 1985 Feb 15; 75(2):689-94. PubMed ID: 2982917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension.
    Semple PF, Mason PA, Fraser R.
    Clin Endocrinol (Oxf); 1980 May 15; 12(5):473-81. PubMed ID: 7428185
    [Abstract] [Full Text] [Related]

  • 15. Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
    Morioka M, Sen Y, Inoue K, Fujita Y.
    J Urol; 1990 Sep 15; 144(3):731-2. PubMed ID: 2388339
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR, Beck FW.
    Acta Endocrinol (Copenh); 1983 Feb 15; 102(2):258-64. PubMed ID: 6338674
    [Abstract] [Full Text] [Related]

  • 17. Effects of corticotrophin-releasing factor and vasopressin on plasma adrenocorticotrophin molecular forms, aldosterone and corticosterone in young and adult rats and rabbits.
    Pradier P, Dalle M.
    Reprod Fertil Dev; 1996 Feb 15; 8(1):111-6. PubMed ID: 8713729
    [Abstract] [Full Text] [Related]

  • 18. Adrenocortical responses to corticotropin-releasing factor in the rat.
    Normand M, Lalonde J.
    Can J Physiol Pharmacol; 1986 Mar 15; 64(3):269-72. PubMed ID: 3011231
    [Abstract] [Full Text] [Related]

  • 19. The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man.
    Conaglen JV, Donald RA, Espiner EA, Livesey JH, Nicholls MG.
    J Clin Endocrinol Metab; 1984 Mar 15; 58(3):463-6. PubMed ID: 6319453
    [Abstract] [Full Text] [Related]

  • 20. Evidence of abnormalities in corticosteroid secretion leading to volume-dependent hypertension in Milan rats.
    Fraser R, Ancil AK, Brown WB, Ingram MC, Holloway CD, Henderson IW, Kenyon CJ.
    Hypertension; 1994 Oct 15; 24(4):512-5. PubMed ID: 8088920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.